Axsome Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AXSM Nasdaq 2834 www.axsome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axsome Therapeutics, Inc.

2 Monster Stocks in the Making - Nov 10th, 2025 2:45 am
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Nov 7th, 2025 6:00 am
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy - Nov 6th, 2025 5:00 am
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics - Nov 6th, 2025 5:00 am
Axsome Therapeutics Stock In A Buy Zone. Analysts See Profit On The Horizon. - Nov 5th, 2025 12:08 pm
Is Axsome Therapeutics Set for More Gains After 54% Rally and Clinical Pipeline News? - Nov 4th, 2025 9:21 am
AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales - Nov 4th, 2025 8:28 am
Axsome Therapeutics (AXSM): Net Margin Stays Negative as Growth Expectations Drive Up Valuation Debate - Nov 4th, 2025 5:16 am
Axsome Therapeutics Inc (AXSM) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Nov 3rd, 2025 12:01 pm
Axsome: Q3 Earnings Snapshot - Nov 3rd, 2025 5:14 am
Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 3rd, 2025 5:00 am
uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Oct 28th, 2025 8:00 am
Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Oct 27th, 2025 8:00 am
Axsome Therapeutics to Participate in Upcoming Investor Conferences - Oct 22nd, 2025 5:00 am
Axsome Therapeutics (AXSM): Exploring Valuation After Recent Share Price Stability - Oct 9th, 2025 10:09 am
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community - Oct 9th, 2025 5:00 am
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3 - Oct 7th, 2025 5:00 am
Piper Sandler Maintains Overweight on Axsome (AXSM), Sees Growth in AD-Agitation - Oct 2nd, 2025 2:55 pm
Can Auvelity Drive Axsome's Growth Through the Rest of 2025? - Sep 30th, 2025 7:45 am
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - Sep 30th, 2025 2:10 am